Arnaud M, Salvo F, Ahmed I, Robinson P, Moore N, Bégaud B, Tubert-Bitter P, Pariente A. A Methodfor the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.
Drug Saf. 2015 Dec 29.
Arnoux-Guenegou A, Girardeau Y, Chen X, Deldossi M, Aboukhamis R, Faviez C, Dahamna B,Karapetiantz P, Guillemin-Lanne S, Lillo-Le Louët A, Texier N, Burgun A, Katsahian S. The Adverse
Drug Reactions From Patient Reports in Social Media Project: Protocol for an Evaluation Against aGold Standard. JMIR Res Protoc. 2019 May 7;8(5):e11448. doi: 10.2196/11448.
Asfari H, Souvignet J, Lillo-Le Louët A, Trombert B, Jaulent MC, Bousquet C. Automated groupingof terms associated to cardiac valve fibrosis in MedDRA. Therapie. 2016 Jul 21.
Bailey C, Peddie D, Wickham ME, Badke K, Small SS, Doyle-Waters MM, Balka E, Hohl CM. Adverse
Drug Event Reporting Systems-a Systematic Review. Br J Clin Pharmacol. 2016 Mar 25.
Bailey J, Thew M, Balls M. An analysis of the use of animal models in predicting human toxicologyand drug safety. Altern Lab Anim. 2014 Jun;42(3):181-99.
Banovac M, Candore G, Slattery J, Houÿez F, Haerry D, Genov G, Arlett P. Patient Reporting in the
EU: Analysis of EudraVigilance Data. Drug Saf. 2017 Apr 17.
Bill RW, Liu Y, McInnes BT, Melton GB, Pedersen T, Pakhomov S. Evaluating semantic relatedness
and similarity measures with Standardized MedDRA Queries. AMIA Annu Symp Proc. 2012;2012:4350.
Botsis T, Woo EJ, Ball R. Application of Information Retrieval Approaches to Case Classification in
the Vaccine Adverse Event Reporting System. Drug Saf. 2013 May 24.
Botsis T, Woo EJ, Ball R. The contribution of the vaccine adverse event text mining system to theclassification of possible GuillainBarré Syndrome reports. Appl Clin Inform. 2013 Feb 27;4(1):88-99.
Bousquet C, Sadou E2, Souvignet J, Jaulent MC, Declerck G. Formalizing MedDRA to support
semantic reasoning on adverse drug reaction terms. J Biomed Inform. 2014 Mar 25. pii: S15320464(14)00079-3.
Bousquet C, Souvignet J, Sadou É, Jaulent MC, Declerck G.

Ontological and Non-Ontological

Resources for Associating Medical Dictionary for Regulatory Activities Terms to SNOMED ClinicalTerms

WithSemantic Properties.

Front Pharmacol.

2019 Sep10; 10:975.

doi:10.3389/fphar.2019.00975. eCollection 2019.
Campillos-Llanos L, Grouin C, Lillo-Le Louët A, Zweigenbaum P.

Initial Experiments for

Pharmacovigilance Analysis in Social Media Using Summaries of Product Characteristics.

StudHealth Technol Inform. 2019 Aug 21; 264:60-64. doi: 10.3233/SHTI190183.
Chang LC, Mahmood R, Qureshi S, Breder CD. Patterns of use and impact of standardised MedDRA
query analyses on the safety evaluation and review of new drug and biologics license applications.
PLoS One. 2017 Jun 1;12(6).
Chernoff M, Ford-Chatterton H, Crain MJ.

The Use of the Medical Dictionary for Regulatory

Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children. Case Studies
Bus Ind Gov Stat. 2012 Oct;5(1):17-31.
Chung AE, Shoenbill K, Mitchell SA, Dueck AC, Schrag D, Bruner DW, Minasian LM, St Germain D,O'Mara AM, Baumgartner P, Rogak LJ, Abernethy AP, Griffin AC, Basch EM. Patient free text
reporting of symptomatic adverse events in cancer clinical research using the National Cancer
Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse
Events(PRO-CTCAE).

JAmMedInformAssoc.

2019

Apr

1;26(4):276-285.

doi:

10.1093/jamia/ocy169.
Combi C, Zorzi M, Pozzani G, Arzenton E, Moretti U. Normalizing Spontaneous Reports into
MedDRA: some Experiments with MagiCoder. IEEE J Biomed Health Inform. 2018 Jul 30. doi:
10.1109/JBHI.2018.2861213.
Combi C, Zorzi M, Pozzani G, Moretti U, Arzenton E. From narrative descriptions to MedDRA:
automagically encoding adverse drug reactions. J Biomed Inform. 2018 Aug;84:184-199. doi:
10.1016/j.jbi.2018.07.001.
Dagenais S, Scranton R, Joyce AR, Vick CC. A comparison of approaches to identify possible cases oflocal anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database.
Expert Opin Drug Saf. 2018 May 10:1-8.
Declerck G, Hussain S, Daniel C, Yuksel M, Laleci GB, Twagirumukiza M, Jaulent MC. Bridging Data
Models and Terminologies to Support Adverse Drug Event Reporting Using EHR Data. Methods Inf
Med. 2015 Jan 12;54(1):24-31.
Declerck G, Souvignet J, Rodrigues JM, Jaulent MC. Automatic annotation of ICD-to-MedDRA

mappings with SKOS predicates. Stud Health Technol Inform. 2014;205:1013-7.
Demner-Fushman D, Shooshan S, Rodriguez L, Aronson AR, Lang F, Rogers W, Roberts K, Tonning
J. A dataset of 200 structured product labels annotated for adverse drug reactions. Sci Data. 2018 Jan30; 5:180001.
de Vries ST, Harrison J, Revelle P, Ptaszynska-Neophytou A, Radecka A, Ragunathan G, Tregunno P,Denig P, Mol PGM. Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form:
A Database Study. Drug Saf. 2019 Feb 6. doi: 10.1007/s40264-019-00800-x
Du J, Cai Y, Chen Y, He Y, Tao C. Analysis of Individual Differences in Vaccine Pharmacovigilance
Using VAERS Data and MedDRA System Organ Classes: A Use Case Study With Trivalent Influenza
Vaccine. Biomed Inform Insights. 2017 Apr 11.
Dupuch M, Dupuch L, Hamon T, Grabar N. Exploitation of semantic methods to cluster
pharmacovigilance terms. J Biomed Semantics. 2014 Apr 16;5(1):18.
Dupuch M, Grabar N. Semantic distance-based creation of clusters of pharmacovigilance terms andtheir evaluation. J Biomed Inform. 2015 Feb 4. pii: S1532-0464(14)00237-8.
Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, Dasgupta N. Digital Drug
Safety Surveillance: Monitoring Pharmaceutical Products in Twitter. Drug Saf. 2014 Apr 29.
Géniaux H, Assaf D, Miremont-Salamé G, Raspaud B, Gouverneur A, Robinson P, Pariente A, Salvo
F. Performance of the Standardised MedDRA® Queries for Case Retrieval in the French Spontaneous
Reporting Database. Drug Saf. 2014 Jun 19.
Gipson DS, Kirkendall ES, Gumbs-Petty B, Quinn T, A. Steen, Hicks A, McMahon A, Nicholas S,Zhao-Wong A, Taylor-Zapata P, Turner M, Herreshoff E, Jones C, Davis JM, Haber M, Hirschfeld S.
Development of a Pediatric Adverse Events Terminology. Pediatrics. 2017 Jan 131:1.
Goss FR, Zhou L, Plasek JM, Broverman C, Robinson G, Middleton B, Rocha RA. Evaluating standard
terminologies for encoding allergy information. J Am Med Inform Assoc. 2013 Feb 9.
Gurulingappa, H J, Rajput, A-M, Toldo, L. Extraction of Adverse Drug Effects from Medical Case
Reports. Biomed Semantics. 2012; 3:15.
Hauben M, Hung E, Wood J, Soitkar A, Reshef D. The impact of database restriction onpharmacovigilance signal detection of selected cancer therapies. Ther Adv Drug Saf. 2017
May;8(5):145-156.
He Y. Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided SystematicCausal Network Analysis toward Integrative Pharmacovigilance Research. Curr Pharmacol Rep.
2016 Jun;2(3):113-128. Epub 2016 Mar 11.
He Y, Sarntivijai S, Lin Y, Xiang Z, Guo A, Zhang S, Jagannathan D, Toldo L, Tao C, Smith,
B. OAE: The Ontology of Adverse Events. Journal of Biomedical Semantics 2014, 5:29.
He Y, Toldo L, Burns G, Tao C, Abernethy DR. A 2012 Workshop: Vaccine and drug ontology in thestudy of mechanism and effect (VDOSME 2012). J Biomed Semantics. 2012 Dec 18;3(1):12.
Hoang T, Liu J, Roughead E, Pratt N, Li J. Supervised signal detection for adverse drug reactions inmedication dispensing data. Comput Methods Programs Biomed. 2018 Jul; 161:25-38.
Hoffman KB, Dimbil M, Kyle RF, Tatonetti NP, Erdman CB, Demakas A, Chen D, Overstreet BM. A
Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events andPatient Outcomes. J Manag Care Spec Pharm. 2015 Dec;21(12):1134-43.
Holländer-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot H. Comparing thepatients' subjective experiences of acute side effects during radiotherapy for head and neck cancer
with four different patient-reported outcomes questionnaires. Acta Oncol. 2019 Jan 30:1-7. doi:
10.1080/0284186X.2018.1563713.
Janssens Y, Nielandt J, Bronselaer A, Debunne N, Verbeke F, Wynendaele E, Van Immerseel F,Vandewynckel YP, De Tré G, De Spiegeleer B. Disbiome database: linking the microbiome to disease.
BMC Microbiol. 2018 Jun 4; 18(1):50.
Karadeniz İ, Özgür A. Linking entities through an ontology using word embeddings and syntactic reranking. BMC Bioinformatics. 2019 Mar 27;20(1):156. doi: 10.1186/s12859-019-2678-8.
Karapetiantz P, Bellet F, Audeh B, Lardon J, Leprovost D, Aboukhamis R, Morlane-Hondère F, GrouinC, Burgun A, Katsahian S, Jaulent MC, Beyens MN, Lillo-Le Louët A, Bousquet C. Descriptions ofAdverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance
Database but Provide More Unexpected Reactions. Front Pharmacol. 2018 May 1; 9:439. 2018.
Karimi S, Kemps M, Metke-Jimenez A, Wang C.2 Cadec: A Corpus of Adverse Drug EventAnnotations. J Biomed Inform. 2015 Mar 26. pii: S1532-0464(15)00053-2.
Köhler S, Doelken SC, Mungall CJ, Bauer S, Firth HV, Bailleul-Forestier I, et al. The HumanPhenotype Ontology project: linking molecular biology and disease through phenotype data. NucleicAcids Res. 2013 Nov 11.
Kronk C, Tran GQ, Wu DTY. Creating a Queer Ontology: The Gender, Sex, and Sexual Orientation(GSSO) Ontology.

Stud Health Technol Inform.

2019 Aug 21; 264:208-212.

doi:

10.3233/SHTI190213.
Kusch MKP, Zien A, Hachenberg C, Haefeli WE, Seidling HM. Information on adverse drug reactionsProof of principle for a structured database that allows customization of drug information. Int J Med
Inform. 2019 Sep 16;133:103970. doi: 10.1016/j.ijmedinf.2019.103970. [Epub ahead of print]
Lamy JB, Thuy VB, Lillo-Le Louët A, Bousquet C1. An Iconic Approach to the Browsing of MedicalTerminologies.

StudHealthTechnolInform.

2019

Aug21;

264:213-217.

doi:

10.3233/SHTI190214.
Lamy JB, Tsopra R. Combining Semantic and Lexical Methods for Mapping MedDRA to VCM Icons.
Stud Health Technol Inform. 2018; 247:905-909.
Lamy JB, Venot A, Duclos C. PyMedTermino: an open-source generic API for advanced terminology
services.Stud Health Technol Inform. 2015; 210:924-8.
Lee S, Han J, Park RW, Kim GJ, Rim JH, Cho J, Lee KH, Lee J, Kim S, Kim J. Development of aControlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic
Health Record-Based Pharmacovigilance. Drug Saf. 2019 Jan 16. doi: 10.1007/s40264-018-0767-7.
Liu J, Xie YM, Gai GZ, Liao X. Application analysis of adverse drug reaction terminology WHOART
and MedDRA Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(24):4728-33. (in Chinese only)
Ly T, Pamer C, Dang O, Brajovic S, Haider S, Botsis T, Milward D, Winter A, Lu S, Ball R. J.
Evaluation of Natural Language Processing (NLP) Systems to Annotate Drug Product Labeling with
MedDRA Terminology. Biomed Inform. 2018 May 31.
Mannil D, Vogt I, Prinz J, Campillos M.

Organ system heterogeneity DB: a database for thevisualization of phenotypes at the organ system level. Nucleic Acids Res. 2014 Oct 13.

Marcilly R, Douze L, Bousquet C, Pelayo S. Modeling Keyword Search Strategy: Analysis of
Pharmacovigilance Specialists' Search of MedDRA Terms. Stud Health Technol Inform. 2019;257:298302.
Martin D, Menschik D, Bryant-Genevier M, Ball R. Data Mining for Prospective Early Detection ofSafety Signals in the Vaccine Adverse Event Reporting System (VAERS): A Case Study of Febrile
Seizures after a 2010-2011 Seasonal Influenza Virus Vaccine. Drug Saf. 2013 May 9.
Maund E, Tendal B, Hróbjartsson A, Lundh A, Gøtzsche PC. Coding of adverse events of suicidality
in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study.
BMJ. 2014 Jun 4;348:g3555.
McEvoy BW, Nandy RR, Tiwari RC. Bayesian approach for clinical trial safety data using an isingprior. Biometrics. 2013 Jul 11.
Nair GJ. Ensuring quality in the coding process: A key differentiator for the accurate interpretationof safety data. Perspect Clin Res. 2013 Jul;4(3):181-5.
Narushima D, Kawasaki Y, Takamatsu S, Yamada H. Adverse events associated with incretin-based
drugs in Japanese spontaneous reports: a mixed effects logistic regression model. PeerJ. 2016 Mar
8;4:e1753.
Patek TM, Teng C, Kennedy KE, Alvarez CA, Frei CR. Comparing Acute Kidney Injury Reports
Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Drug Saf. 2019 Oct 18. doi: 10.1007/s40264-019-00873-8. [Epub ahead of print]
Patel R, Belousov M, Jani M, Dasgupta N, Winokur C, Nenadic G, Dixon WG. Frequent discussion ofinsomnia and weight gain with glucocorticoid therapy: An analysis of Twitter posts. NPJ Digit Med.
2018 Feb 12;1. doi: 10.1038/s41746-017-0007-z.
Putrik P, Ramiro S, Lie E, Michaud K, Kvamme MK, Keszei AP, Kvien TK, Uhlig T, Boonen. Deriving
common comorbidity indices from the MedDRA classification and exploring their performance on key
outcomes in patients with rheumatoid arthritis. ARheumatology (Oxford). 2017 Dec 19.
Radhakrishna, P. Upversioning MedDRA Dictionary - Insights from a Seasoned Coder. Data Basics.
Vol 20:3. Fall 2014.
Reumann M, Giovannini A, Nadworny B, Auer C, Girardi I, Marchiori C. Cognitive DDx Assistant inRare

Diseases.

Conf

Proc

IEEEEng

Med

BiolSoc.

2018

Jul;2018:3244-3247.

doi:10.1109/EMBC.2018.8513041.
Salaets T, Turner MA, Short M, Ward RM, Hokuto I, Ariagno RL, Klein A, Beauman S, Wade K,Thomson M, Roberts E, Harrison J, Quinn T, Baer G, Davis J, Allegaert K. International Neonatal
Consortium. Development of a neonatal adverse event severity scale through a Delphi consensus
approach. Arch Dis Child. 2019 Sep 19. pii: archdischild-2019-317399. doi: 10.1136/archdischild2019-317399.
Sarntivijai S, Zhang S, Jagannathan DG, Zaman S, Burkhart KK, Omenn GS, He Y, Athey B,Abernethy DR. Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by theOntology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors. Drug Saf. 2016 Mar 22.
Sarntivijai S, Xiang Z, Shedden KA, Markel H, Omenn GS, Athey BD, He Y. Ontology-based
combinatorial comparative analysis of adverse events associated with killed and live influenza
vaccines. PLoS One. 2012;7(11). Epub 2012 Nov 28.
Slikker W Jr, de Souza Lima TA, Archella D, de Silva JB Junior, Barton-Maclaren T, Bo L, Buvinich
D, Chaudhry Q, Chuan P, Deluyker H, Domselaar G, Freitas M, Hardy B, Eichler HG, Hugas M, LeeK, Liao CD, Loo LH, Okuda H, Orisakwe OE, Patri A, Sactitono C, Shi L, Silva P, Sistare F, Thakkar
S, Tong W, Valdez ML, Whelan M, Zhao-Wong A. Emerging technologies for food and drug safety.
Regul Toxicol Pharmacol. 2018 Jul 23;98:115-128. doi: 10.1016/j.yrtph.2018.07.013.
Souvignet J, Declerck G, Asfari H, Jaulent MC, Bousquet C. OntoADR a semantic resource describing
adverse drug reactions to support searching, coding, and information retrieval. J Biomed Inform. 2016
Oct;63:100-107.
Souvignet J, Declerck G, Trombert B, Rodrigues JM, Jaulent MC, Bousquet C. Evaluation ofautomated term groupings for detecting anaphylactic shock signals for drugs. AMIA Annu Symp Proc.
2012;2012:882-90.
Souvignet J, Declerck G, Trombert-Paviot B, Asfari H, Jaulent MC, Bousquet C. Semantic Queries
Expedite MedDRA Terms Selection Thanks to a Dedicated User Interface: A Pilot Study on Five
Medical Conditions. Front Pharmacol. 2019 Feb 6;10:50. doi: 10.3389/fphar.2019.00050. eCollection
2019.
Tao C, He Y, Arabandi S. Vaccine and Drug Ontology Studies (VDOS 2014). J Biomed Semantics. 2016Feb 25;7:6.

Tao C, Du J, Cai Y, Chen Y. Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA
System Organ Classes Using VAERS Data. Stud Health Technol Inform. 2015;216:1076.
Tao C, He Y, Arabandi S. A 2013 workshop: vaccine and drug ontology studies (VDOS 2013). J Biomed
Semantics. 2014 Mar 20; 5(1):16.
Tiftikci M, Özgür A, He Y, Hur J. Machine learning-based identification and rule-based normalizationof adverse drug reactions in drug labels. BMC Bioinformatics. 2019 Dec 23;20(Suppl 21):707. doi:
10.1186/s12859-019-3195-5. PMID: 31865904
van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O, Dasgupta N, Dietrich J, Gama S,Lewis D, Newbould V, Brosch S, Pierce CE, Powell G, Ptaszyńska-Neophytou A, Wiśniewski AFZ,Tregunno P, Norén GN, Pirmohamed M. Recommendations for the Use of Social Media in
Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Saf. 2019 Aug 24. doi: 10.1007/s40264019-00858-7.
Vidal C, Rodríguez Del Río P, Gude F, Casale T, Cox L, Just J, Pfaar O, Demoly P, Calderón MA.
Comparison of International Systemic Adverse Reactions due to Allergen Immunotherapy. J Allergy
Clin Immunol Pract. 2018 Dec 14. pii: S2213-2198(18)30826-2. doi: 10.1016/j.jaip.2018.12.006.
Wang L, Jiang G, Li D, Liu H. Standardizing adverse drug event reporting data. J Biomed Semantics.
2014 Aug 12;5:36.
Wang L, Jiang G, Li D, Liu H. Standardizing drug adverse event reporting data. Stud Health TechnolInform. 2013; 192:1101.
Ward DS, Williams MR, Berkenbosch JW, Bhatt M, Carlson D, Chappell P, Clark RM, Constant I,Conway A, Cravero J, Dahan A, Dexter F, Dionne R, Dworkin RH, Gan TJ, Gozal D, Green S, Irwin
MG, Karan S, Kochman M, Lerman J, Lightdale JR, Litman RS, Mason KP, Miner J, O'Connor RE,Pandharipande P, Riker RR, Roback MG, Sessler DI, Sexton A, Tobin JR, Turk DC, Twersky RS,Urman RD, Weiss M, Wunsch H, Zhao-Wong A. Evaluating Patient-Centered Outcomes in Clinical
Trials of Procedural Sedation, Part 2 Safety: Sedation Consortium on Endpoints and Procedures for
Treatment, Education, and Research Recommendations. Anesth Analg. 2018 May 17.
Wu L, Ingle T, Liu Z, Zhao-Wong A, Harris S, Thakkar S, Zhou G, Yang J, Xu J, Mehta D, Ge W, Tong
W, Fang H. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
BMC Bioinformatics. 2019 Mar 14;20(Suppl 2):97. doi: 10.1186/s12859-019-2628-5.

Xie J, He Y. Ontology-Based Vaccine Adverse Event Representation and Analysis. Adv Exp Med Biol.
2017;1028:89-103.
Xie J, Zhao L, Zhou S, He Y. Statistical and Ontological Analysis of Adverse Events Associated withMonovalent and Combination Vaccines against Hepatitis A and B Diseases. Sci Rep. 2016 Oct
3;6:34318.
Yu Y, Ruddy KJ, Hong N, Tsuji S, Wen A, Shah ND, Jiang G. ADEpedia-on-OHDSI: A Next Generation
Pharmacovigilance Signal Detection Platform Using the OHDSI Common Data Model. J Biomed
Inform. 2019 Feb 7:103119. doi: 10.1016/j.jbi.2019.103119.
Yu Y, Ruddy KJ, Tsuji S, Hong N, Liu H, Shah N, Jiang G. Coverage Evaluation of CTCAE for
Capturing the Immune-related Adverse Events Leveraging Text Mining Technologies. AMIA Jt
Summits Transl Sci Proc. 2019 May 6;2019:771-778. eCollection 2019.
Zhai Y, Ye X, Hu F, Xu J, Guo X, Zhuang Y, He J. Endocrine toxicity of immune checkpoint inhibitors:
a real-world study leveraging US Food and Drug Administration adverse events reporting system. J
Immunother Cancer. 2019 Nov 6;7(1):286. doi: 10.1186/s40425-019-0754-2.